Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams

Nervous System Diseases Clinical Trial

Official title:

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00739518
• Other study ID #: HUM00041731
• Status: Completed
• Phase: N/A
• Start date: October 2004
• Est. completion date: January 14, 2020

Study information

• Verified date: March 2021
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.

Description:

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions. Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: January 14, 2020
• Est. primary completion date: January 14, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• If you are a male or a non-pregnant female patient
• Normal volunteer
• presenting to MRI for a clinically-ordered neurological or head and neck MRI exam

Exclusion Criteria:

• Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
• Pregnant patients or patients who are lactating.
• A patient who is claustrophobic

Related Conditions & MeSH terms

• Nervous System Diseases

Intervention

Procedure:
• MRI
Neurological MRI with new technology evaluation. The new technology may involve software or MRI scanning sequences. This is a long term research study that focuses on new technology that is constantly being created.

Locations

Country	Name	City	State
United States	University of Michigan Health System	Ann Arbor	Michigan

Sponsors (3)

Lead Sponsor	Collaborator
University of Michigan	General Electric, Philips Medical Systems

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Improvement in quality of MRI studies in Neuroradiology	Specific Measurement Are: Scan speed - is the new method as fast or faster than regular method(s); Signal to noise - Subjectively, or quantitatively do we get the same, better, or new contrast compared to the regular methods(s).; Image contrast - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).; Spatial resolution - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).; Artifact - Subjectively, or quantitatively do we get the better artifact reduction compared to the regular method(s).; Ergonomics - Is the new software easier to work or offer more information more cleanly than the regular software; Patient comfort - Subjectively, does the new software and/or hardware make the patient's MRI experience more comfortable.	1 year